Project Grant R01DK145055
- Federal Project Grant Award Summary Beth Israel Deaconess Medical Center, Inc. received a $834,911 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective April 1, 2026, with a completion date of January 31, 2031. The award supports basic biomedical research aimed at elucidating selective brain-to-gut communication pathways through...
- Federal Project Grant Award Summary Harvard Medical School received a $1,660,828 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded on August 13, 2025, with completion targeted for May 31, 2030. The research will be conducted in Boston, Massachusetts, and focuses on identifying and characterizing microbiome-derived sulfated metabolites—underexplored...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Johns Hopkins University a Project Grant of $725,520 beginning September 15, 2025, and concluding June 30, 2030, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research focuses on understanding aberrant N-glycosylation in Crohn's disease as a precision medicine opportunity. The project investigates the role of manganese...
- Federal Grant Award Summary Cincinnati Children's Hospital Medical Center received a $824,078 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded April 1, 2026, with a completion date of January 31, 2030. The award funds a comprehensive research initiative titled "From Real-World Evidence to Systems Pharmacology: A Comprehensive Approach to...
- Federal Project Grant Award Summary Boston University Medical Campus received a $703,748 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 1, 2026, with completion targeted for February 28, 2030. This grant funds basic biomedical research designed to elucidate the role of bacterial polyphosphates in exacerbating intestinal inflammation and...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $2,076,999 to the University of Colorado-Denver on September 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for a four-year project period extending through September 14, 2029. This Project Grant supports basic biomedical research investigating the role of mitochondrial dysfunction in Paneth cells as a mediator of inflammatory...
- Federal Project Grant Award Summary Mayo Clinic received a $242,100 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to support research on sphingolipid metabolism in regulatory T cell function and intestinal homeostasis. The award, effective September 15, 2025, through August 31, 2027, is designed to generate preliminary data for a planned R01...
- Federal Grant Award Summary The University of Michigan received a $580,568 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025, through June 30, 2029. This award supports biomedical research investigating the role of CD45 (a tyrosine phosphatase) in regulating neutrophil function during intestinal inflammation, with particular...
- Federal Grant Award Summary Yale University received a $3.23 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025, through August 31, 2029. The award supports investigator-initiated biomedical research focused on understanding the role of neutrophils in the pathogenesis of cholangiopathies—a group of bile duct diseases...
- Federal Project Grant Award Summary Weill Medical College of Cornell University received a $1.71M project grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded July 2, 2025, with completion scheduled for April 30, 2029. The award funds biomedical research investigating the role of Anterior Gradient 2 (AGR2), an endoplasmic reticulum protein, in regulating...
Dartmouth-Hitchcock Clinic received a $796,394 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) beginning July 1, 2026, with completion scheduled for April 30, 2030. The award funds research investigating bile acid-dependent intestinal immune regulation, with the primary deliverables consisting of scientific research outputs and empirical findings that advance understanding of how bile acids function as immunoregulatory metabolites in the intestines. The research involves developing integrated methodological approaches to quantify intestinal bile acid pools in mice, characterizing how these pools change during intestinal inflammation, and mapping interactions between bile acids and host intestinal cells and receptors. The project employs advanced computational modeling and in vivo experimental techniques to examine the enterohepatic circulation of bile acids, with particular focus on understanding alterations in bile acid metabolism associated with Crohn's disease-like ileitis. Key research products include quantitative data on bile acid pool dynamics, computational models calibrated to in vivo datasets, and mechanistic insights into how cytokine-driven changes in bile acid absorption transporters contribute to pro-inflammatory intestinal states. These deliverables are intended to inform basic and clinical understanding of bile acid signaling pathways and their role in intestinal immune homeostasis, ultimately contributing to improved prevention and treatment strategies for inflammatory bowel diseases.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $796.4k | 6/19/26 |